DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Biotest GmbH & Co. KGaA

OTCPK:BIES.F Stock Report

Market Cap: US$1.6b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Biotest Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Peter Janssen

Chief executive officer

€926.0k

Total compensation

CEO salary percentage47.52%
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure3.4yrs
Board average tenure3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Peter Janssen's remuneration changed compared to Biotest's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-€24m

Dec 31 2024n/an/a

€26m

Sep 30 2024n/an/a

€69m

Jun 30 2024n/an/a

€164m

Mar 31 2024n/an/a

€177m

Dec 31 2023€926k€440k

€127m

Sep 30 2023n/an/a

€91m

Jun 30 2023n/an/a

-€10m

Mar 31 2023n/an/a

-€47m

Dec 31 2022€333k€147k

-€32m

Compensation vs Market: Peter's total compensation ($USD1.06M) is below average for companies of similar size in the US market ($USD6.08M).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.


CEO

Peter Janssen (59 yo)

2.8yrs
Tenure
€926,000
Compensation

Mr. Peter Janssen serves as Member of Management Board for Biotest Aktiengesellschaft since September 1, 2022 and served as its Chief Operating Officer since September 2022 until December 31, 2023. He has...


Leadership Team

NamePositionTenureCompensationOwnership
Peter Janssen
CEO & Chairman of the Board of Management2.8yrs€926.00kno data
Dirk Schuck
Employee Representative Member of Supervisory Board3.4yrs€44.00kno data
Monika Buttkereit
Head of Investor Relationsno datano datano data
Christina Erb
Head of Corporate HR9.8yrsno datano data
3.4yrs
Average Tenure

Experienced Management: BIES.F's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Dirk Schuck
Employee Representative Member of Supervisory Board3.1yrs€44.00kno data
Raimon Grifols Roura
Member of Supervisory Board2.1yrs€29.00kno data
Bernhard R. Ehmer
Chairman of the Supervisory Board3.1yrs€132.00kno data
Gernot Hebestreit
Shareholder Representative Member of Supervisory Boardless than a yearno datano data
David Bell
Shareholder Representative Member of Supervisory Board3yrs€44.00kno data
Jurgen Heilmann
Employee Representative Member of Supervisory Board13.8yrs€44.00kno data
3.0yrs
Average Tenure
62.5yo
Average Age

Experienced Board: BIES.F's board of directors are considered experienced (3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/07 21:12
End of Day Share Price 2025/03/10 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biotest GmbH & Co. KGaA is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Torben TeichlerHauck Aufhäuser Investment Banking
Jan KeppelerHSBC
Klaus SchloteSolventis Wertpapierhandelsbank GmbH

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide